Controlling Skin Cancer in Renal Transplant Patients - Medscape

Controlling Skin Cancer in Renal Transplant Patients Medscape Today I want to talk to you about the use of conversion to sirolimus-based immunosuppression in patients who develop excessive numbers of skin cancers after ...

Read more...

---

Syntax Score Incorporating Clinical Variables Improves PCI Risk Prediction - TCTMD

Syntax Score Incorporating Clinical Variables Improves PCI Risk Prediction TCTMD ... safety and efficacy of sirolimus-eluting stents in 607 patients with de novo multivessel CAD, using the surgical group of ARTS-I as historical controls. ...

Read more...

---

CORNETT v. JOHNSON & JOHNSON - Leagle.com

CORNETT v. JOHNSON & JOHNSON Leagle.com The drug-eluting stent at issue here is Cordis' Cypher stent, which Cordis coated with sirolimus, a chemotherapy drug from Wyeth that slows cell growth and, ...

Read more...

---

Siemens Showcases Broad Array of Innovative Diagnostic Solutions at 2010 AACC ... - PR Newswire (press release)

Siemens Showcases Broad Array of Innovative Diagnostic Solutions at 2010 AACC ... PR Newswire (press release) ... Integrated Chemistry Systems, this full menu of ISD tests now includes Cyclosporine, Cyclosporine Extended Range, Tacrolimus and Sirolimus assays. ... and more »

Read more...

---

New Jersey appeals court issues mixed ruling in Cordis stent liability case - Mass Device

New Jersey appeals court issues mixed ruling in Cordis stent liability case Mass Device Although the court affirmed the dismissal of some of the claims in lawsuits against Cordis over its Cypher sirolimus-eluting stent, it reversed the ...

Read more...

---

SES Superior to BMS for Chronic Total Occlusions - TCTMD

SES Superior to BMS for Chronic Total Occlusions TCTMD In chronic total occlusions (CTOs), treatment with sirolimus-eluting stents (SES) results in less restenosis at 8 months compared with ...

Read more...

---

Beyond the Abstract - An update on targeted therapy in metastatic renal cell ... - UroToday

Beyond the Abstract - An update on targeted therapy in metastatic renal cell ... UroToday Numerous trials have tested combination regimens such as bevacizumab plus erlotinib, bevacizumab plus sorafenib, erlotinib with sirolimus; however, ...

Read more...

---